Dyslipidemia patterns and associated factors in Wilson's disease patients: a clinical analysis

被引:0
|
作者
Wu, Rong [1 ]
Luo, Xingguang [2 ]
Wang, Xiao-Ping [3 ]
机构
[1] Shanghai Jiao Tong Univ, TongRen Hosp, Sch Med, Dept Neurol, Shanghai, Peoples R China
[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[3] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
Wilson's disease; dyslipidemia; influencing factors; regression analysis; lipidemia metabolism; SPLENECTOMY; SPLEEN;
D O I
10.3389/fneur.2024.1411236
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective This study aims to analyze the lipid metabolism patterns and identify risk factors for dyslipidemia in Wilson's Disease (WD), offering novel insights into diagnosis and treatment strategies for unexplained dyslipidemia.Methods Data from Wilson's disease patients hospitalized at the First People's Hospital of Shanghai from December 2008 to February 2015 were collected. Patients were categorized into normal lipid (46 cases) and dyslipidemia (42 cases) groups based on lipid levels. Group analyzes were conducted using t-tests, chi-square analysis, and rank sum tests. Spearman correlation, multiple linear regression, or Logistic regression were employed to identify relevant influencing factors.Results 1. The incidence of abnormal blood lipids in a series of Wilson's disease patients was 47.73% (25.12 +/- 1.29 years old), and the incidence of control healthy group was 27.40%, with proportions of hypercholesterolemia, hypertriglyceridemia, and low-density lipoprotein cholesterol being 14.77, 30.68, and 29.63%, respectively; 2. Significant differences were observed between the dyslipidemia and normal WD groups in AST/ALT ratio, liver parenchymal echo, liver surface, spleen area, and ultrasound total score.3. Low-and high-density lipoprotein cholesterols (LDL-c and HDL-c) showed no significant correlation with these indicators. Triglyceride (TG) exhibited moderately negative correlation with AST/ALT, liver parenchymal echo, spleen area, and ultrasound score. Total cholesterol (TC) displayed low negative correlation with these factors.Conclusion 1. Dyslipidemia incidence in Wilson's disease patients may exceed that of the normal population, especially in adolescents with unexplained abnormal lipid metabolism; 2. Patients with mild to moderate liver damage are predisposed to elevated triglycerides and total cholesterol, reflecting liver damage impact on lipid metabolism; 3. Glucose metabolism is not implicated in WD-related dyslipidemia; 4. No significant correlation was found between abnormal lipid metabolism and blood concentration of trace elements in WD patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Analysis of Running in Wilson's Disease
    Samadzadeh, Sara
    Hefter, Harald
    Tezayak, Osman
    Rosenthal, Dietmar
    SPORTS, 2022, 10 (01)
  • [22] Computer-assisted analysis of handwriting in patients with Wilson's disease
    Hermann, W.
    Guenther, P.
    Kuehn, H. J.
    Villmann, T.
    Wagner, A.
    KLINISCHE NEUROPHYSIOLOGIE, 2007, 38 (03) : 185 - 189
  • [23] Patterns and Factors Associated with Dyslipidemia Among Patients with Diabetes Mellitus Attending Hoima Regional Referral Hospital, Uganda
    Hirsi, Abishir Mohamud
    Abdi, Awil Abdukadir
    Peris, Alina
    Jacinto, Amandua
    Muhammad, Propser
    Nur, Ibrahim Ahmed
    Mohamud, Muktar Hassan
    Hussein, Mustafa
    Qaws, Abdi
    Jayte, Mohamed
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2025, 18 : 73 - 86
  • [24] Pattern of dyslipidemia and associated factors in coronary artery disease patients in Khyber Pakhtunkhwa: A cross-sectional secondary data analysis
    Hussain, Arif
    Zakria, Muhammad
    Ali, Iftikhar
    Tariq, Shafiq Ahmad
    Hussain, Arshad
    Siraj, Sami
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (05) : 1416 - 1421
  • [25] Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia
    Alefishat, Eman
    Jarab, Anan S.
    Al-Qerem, Walid
    Abu-Zaytoun, Lina
    HEALTHCARE, 2021, 9 (07)
  • [26] Modifying factors and phenotypic diversity in Wilson's disease
    Lutsenko, Svetlana
    HUMAN DISORDERS OF COPPER METABOLISM II, 2014, 1315 : 56 - 63
  • [27] Unified Wilson's Disease Rating Scale - a proposal for the neurological scoring of Wilson's disease patients
    Cztonkowska, Anna
    Tarnacka, Beata
    Moeller, Jens Carsten
    Leinweber, Barbara
    Bandmann, Oliver
    Woimant, France
    Oertel, Wolfgang H.
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2007, 41 (01) : 1 - 12
  • [28] Dyslipidemia and associated factors among hypertensive patients in Ethiopia: a systematic review and meta-analysis
    Worku Chekol Tassew
    Samson Sisay Woldie
    Yeshiwas Ayale Ferede
    Agerie Mengistie Zeleke
    Adane Nigussie
    BMC Cardiovascular Disorders, 25 (1)
  • [29] Aortic stiffness in patients with wilson's disease
    Gurbuz, A. S.
    Ozturk, S.
    Efe, S. C.
    Demir, K.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2019, 22 (08) : 1120 - 1125
  • [30] Olfactory dysfunction in patients with Wilson?s Disease
    Piechal, Agnieszka
    Bembenek, Jan
    Baranowska, Anna
    Litwin, Tomasz
    Mirowska-Guzel, Dagmara
    Czlonkowska, Anna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2023, 57 (02) : 212 - 218